RZLT

Rezolute Inc. Common Stock (NV) (RZLT)

Stock · NASDAQ · Health Care

$4.63as of 8/28/2026

Active signals

Support level
$3.08
Industry
Biotechnology: Pharmaceutical Preparations

About RZLT

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypogl…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
68

Fundamentals

1-day range
$4.44$4.75
Market cap
$452.57M
P/E (trailing)
P/E (forward)
-7.35
EPS (trailing)
$-0.81
Dividend yield
Beta
0.62
Avg. volume
1.81M
Dividend pay date
October 13, 2020
52-week range
$1.07$11.46
Next earnings: September 16, 2026 · EPS estimate $-0.14After Closeconfirmed

Forecasts

9 analyst ratings

Buy 80%
Hold 20%
Sell 0%
1-year price forecast
High
$14
+202.4%
Median
$6
+29.6%
Low
$4
-13.6%

Rezolute Inc. Common Stock (NV) Competitors

Chosen by industry and closest market cap.

  • RZLT
    Rezolute Inc. Common Stock (NV)
    $4.62
    ▼ 7.23%
    Market cap $452.57MP/E
    $1.07$11.46
  • BNTC
    Benitec Biopharma Inc. Common Stock
    $12.51
    ▼ 1.30%
    Market cap $451.07MP/E
    $9.85$16.76
  • PRTA
    Prothena Corporation plc Ordinary Shares
    $9.35
    ▲ 2.86%
    Market cap $449.19MP/E
    $7.73$11.8
  • LRMR
    Larimar Therapeutics Inc. Common Stock
    $4
    ▼ 1.23%
    Market cap $436.31MP/E
    $2.72$6.42
  • QTTB
    Q32 Bio Inc. Common Stock
    $15.01
    ▼ 7.06%
    Market cap $482.18MP/E 15.71
    $1.62$23.57
  • EOLS
    Evolus Inc. Common Stock
    $8.89
    ▲ 0.06%
    Market cap $487.98MP/E
    $3.86$9.12
  • AQST
    Aquestive Therapeutics Inc. Common Stock
    $5.02
    ▼ 2.71%
    Market cap $491.83MP/E

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
10.0K
Disposed
64.6K

Institutional Ownership

March 31, 2026

Total shares held
83.96M
Total value held
$254.91M
Institutional holders
122
Top holders this quarter
  • Unknown12.99M
  • Unknown9.18M
  • Unknown6.31M
  • Unknown6.30M
  • Unknown5.05M
  • Unknown3.52M
  • Unknown3.44M
  • Unknown3.33M
  • Unknown2.97M
  • Unknown2.75M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.